|

EWALL-PH OBSERVARTORY 2022

RECRUITINGSponsored by Versailles Hospital
Actively Recruiting
SponsorVersailles Hospital
Started2024-01-15
Est. completion2027-06-15
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07684131

Summary

An observatory for patients aged 18 years and over with Philadelphia chromosome positive (Ph+ or BCR::ABL1) acute lymphoblastic leukemia (ALL) and treated with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticosteroids and/or a monoclonal antibody.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Male or female patients ≥ 18 years
2. Philadelphia chromosome or BCR::ABL1 positive acute lymphoblastic leukaemia
3. Treatment with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticotherapy and/or a monoclonal antibody

Exclusion Criteria:

1. Patients deceded and having previously refused data collection
2. Not included in a prospective clinical trial

Conditions2

Acute Lymphoblastic LeukemiaCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.